XPH Holdings Information

XPH is an equity ETF with a total of 59 individual holdings. The top holdings are Definium Therapeutics stock at 2.77%, Nektar Therapeutics at 2.45%, Viatris at 2.45%, Edgewise Therapeutics at 2.34%, and Royalty Pharma at 2.33%.

Total Holdings

Top 10 Percentage

23.81%

Asset Class

Equity

ETF Category

Health

Assets

325.25M

PE Ratio

16.73

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	DFTX	Definium Therapeutics, Inc.	2.77%	501,891
2	NKTR	Nektar Therapeutics	2.45%	107,610
3	VTRS	Viatris Inc.	2.45%	535,639
4	EWTX	Edgewise Therapeutics, Inc.	2.34%	261,727
5	RPRX	Royalty Pharma plc	2.33%	162,400
6	MRK	Merck & Co., Inc.	2.32%	63,649
7	BMY	Bristol-Myers Squibb Company	2.32%	121,332
8	SUPN	Supernus Pharmaceuticals, Inc.	2.30%	134,606
9	JNJ	Johnson & Johnson	2.27%	30,083
10	PAHC	Phibro Animal Health Corporation	2.26%	144,536
11	ELAN	Elanco Animal Health Incorporated	2.20%	291,709
12	LGND	Ligand Pharmaceuticals Incorporated	2.19%	33,763
13	JAZZ	Jazz Pharmaceuticals plc	2.18%	37,664
14	PBH	Prestige Consumer Healthcare Inc.	2.16%	101,262
15	ELVN	Enliven Therapeutics, Inc.	2.16%	234,353
16	MBX	MBX Biosciences, Inc.	2.13%	215,594
17	AMRX	Amneal Pharmaceuticals, Inc.	2.12%	508,879
18	AXSM	Axsome Therapeutics, Inc.	2.12%	41,628
19	INVA	Innoviva, Inc.	2.10%	301,329
20	AMLX	Amylyx Pharmaceuticals, Inc.	2.08%	469,645
21	LQDA	Liquidia Corporation	2.07%	190,129
22	ARVN	Arvinas, Inc.	2.03%	469,074
23	ZTS	Zoetis Inc.	2.02%	52,625
24	PFE	Pfizer Inc.	2.02%	241,017
25	MAZE	Maze Therapeutics, Inc.	1.99%	139,366

Showing 25 of 59 holdings

Subscribe to see the full list

Activate Now

As of Mar 5, 2026